Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

Transferrin receptor in T cell activation and transplantation.

Bayer AL, Baliga P, Woodward JE.

J Leukoc Biol. 1998 Jul;64(1):19-24.

PMID:
9665270
2.

Differential effects of transferrin receptor blockade on the cellular mechanisms involved in graft rejection.

Bayer AL, Baliga P, Woodward JE.

Transpl Immunol. 1999 Sep;7(3):131-9.

PMID:
10608296
3.

Enhanced allograft survival via simultaneous blockade of transferrin receptor and interleukin-2 receptor.

Woodward JE, Bayer AL, Baliga P.

Transplantation. 1999 Nov 15;68(9):1369-76.

PMID:
10573078
4.

T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.

Woodward JE, Bayer AL, Chavin KD, Blue ML, Baliga P.

Transplantation. 1998 Jul 15;66(1):14-20.

PMID:
9679816
5.

Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.

Chavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS.

Transplantation. 1993 Apr;55(4):901-8.

PMID:
8097344
6.

Anti-transferrin receptor monoclonal antibody: a novel immunosuppressant.

Woodward JE, Bayer AL, Chavin KD, Boleza KA, Baliga P.

Transplantation. 1998 Jan 15;65(1):6-9.

PMID:
9448136
7.

Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.

Lei J, He F, Wu M, Zheng X, Chen X, Chen Z.

Transpl Int. 2010 Dec;23(12):1271-81. doi: 10.1111/j.1432-2277.2010.01125.x.

8.

Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.

Chavin KD, Qin L, Lin J, Yagita H, Bromberg JS.

J Immunol. 1993 Dec 15;151(12):7249-59.

PMID:
7903105
9.

Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice.

Xia D, Sanders A, Shah M, Bickerstaff A, Orosz C.

Transplantation. 2001 Sep 15;72(5):907-14.

PMID:
11571458
10.

Differential Th1 and Th2 cell regulation of murine cardiac allograft acceptance by blocking cell adhesion of ICAM-1/LFA-1 and VCAM-1/VLA-4.

Suzuki J, Isobe M, Izawa A, Takahashi W, Yamazaki S, Okubo Y, Amano J, Sekiguchi M.

Transpl Immunol. 1999 Mar;7(1):65-72.

PMID:
10375080
11.

Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.

Qin L, Ding Y, Tahara H, Bromberg JS.

J Immunol. 2001 Feb 15;166(4):2385-93.

13.
14.

Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.

Smith XG, Bolton EM, Ruchatz H, Wei X, Liew FY, Bradley JA.

J Immunol. 2000 Sep 15;165(6):3444-50.

15.

Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.

Li W, Fu F, Lu L, Narula SK, Fung JJ, Thomson AW, Qian S.

Transplantation. 1998 Dec 27;66(12):1587-96.

PMID:
9884244
16.

Monoclonal antibody specific for TIRC7 induces donor-specific anergy and prevents rejection of cardiac allografts in mice.

Kumamoto Y, Tomschegg A, Bennai-Sanfourche F, Boerner A, Kaser A, Schmidt-Knosalla I, Heinemann T, Schlawinsky M, Blumberg RS, Volk HD, Utku N.

Am J Transplant. 2004 Apr;4(4):505-14.

17.

Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses.

He XY, Chen J, Verma N, Plain K, Tran G, Hall BM.

Transplantation. 1998 May 15;65(9):1145-52.

PMID:
9603159
18.

Prolongation of allograft survival by administration of mAb specific for the three subunits of IL-2 receptor.

Yasuda K, Nemoto T, Ohashi Y, Satomi S, Murata K, Ishii N, Takeshita T, Sugamura K.

Int Immunol. 1998 May;10(5):561-7.

PMID:
9645604
19.
20.

Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.

Pollak R, Blanchard JM.

Transplantation. 2000 Jun 15;69(11):2432-9.

PMID:
10868654

Supplemental Content

Support Center